Literature DB >> 18258796

Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.

Farshid Dayyani1, Jianfeng Wang, Jing-Ruey J Yeh, Eun-Young Ahn, Erica Tobey, Dong-Er Zhang, Irwin D Bernstein, Randall T Peterson, David A Sweetser.   

Abstract

Deletions on chromosome 9q are seen in a subset of acute myeloid leukemia (AML) cases and are specifically associated with t(8;21) AML. We previously defined the commonly deleted region in del(9q) AML and characterized the genes in this interval. To determine the critical lost gene(s) that might cooperate with the AML1-ETO fusion gene produced by t(8;21), we developed a set of shRNAs directed against each gene in this region. Within this library, shRNAs to TLE1 and TLE4 were the only shRNAs capable of rescuing AML1-ETO expressing U937T-A/E cells from AML1-ETO-induced cell-cycle arrest and apoptosis. Knockdown of TLE1 or TLE4 levels increased the rate of cell division of the AML1-ETO-expressing Kasumi-1 cell line, whereas forced expression of either TLE1 or TLE4 caused apoptosis and cell death. Knockdown of Gro3, a TLE homolog in zebrafish, cooperated with AML1-ETO to cause an accumulation of noncirculating hematopoietic blast cells. Our data are consistent with a model in which haploinsufficiency of these TLEs overcomes the negative survival and antiproliferative effects of AML1-ETO on myeloid progenitors, allowing preleukemic stem cells to expand into AML. This study is the first to implicate the TLEs as potential tumor suppressor genes in myeloid leukemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258796      PMCID: PMC2288729          DOI: 10.1182/blood-2007-07-103291

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  74 in total

1.  Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.

Authors:  Katharina H Ruebel; Alexey A Leontovich; Long Jin; Gail A Stilling; Heyu Zhang; Xiang Qian; Nobuki Nakamura; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

2.  A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.

Authors:  Ming Yan; Eiki Kanbe; Luke F Peterson; Anita Boyapati; Yuqin Miao; Yang Wang; I-Ming Chen; Zixing Chen; Janet D Rowley; Cheryl L Willman; Dong-Er Zhang
Journal:  Nat Med       Date:  2006-07-30       Impact factor: 53.440

3.  Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.

Authors:  Sandrine Rorive; Calliope Maris; Olivier Debeir; Flavienne Sandras; Michel Vidaud; Ivan Bièche; Isabelle Salmon; Christine Decaestecker
Journal:  J Neuropathol Exp Neurol       Date:  2006-08       Impact factor: 3.685

4.  Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.

Authors:  David A Sweetser; Andrew J Peniket; Christina Haaland; Adam A Blomberg; Yuntian Zhang; Syed Tanweer Zaidi; Farshid Dayyani; Zheng Zhao; Nyla A Heerema; Jacqueline Boultwood; Gordon W Dewald; Elisabeth Paietta; Marilyn L Slovak; Cheryl L Willman; James S Wainscoat; Irwin D Bernstein; Sarah B Daly
Journal:  Genes Chromosomes Cancer       Date:  2005-11       Impact factor: 5.006

5.  Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

Authors:  Y Ravindranath; M Chang; C P Steuber; D Becton; G Dahl; C Civin; B Camitta; A Carroll; S C Raimondi; H J Weinstein
Journal:  Leukemia       Date:  2005-12       Impact factor: 11.528

6.  Meningioma transcript profiles reveal deregulated Notch signaling pathway.

Authors:  Ileana C Cuevas; Alison L Slocum; Peter Jun; Joseph F Costello; Andrew W Bollen; Gregory J Riggins; Michael W McDermott; Anita Lal
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

7.  Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses.

Authors:  Carlos S Moreno; Chheng-Orn Evans; Xianquan Zhan; Mammerhi Okor; Dominic M Desiderio; Nelson M Oyesiku
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

8.  Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.

Authors:  Joseph D Growney; Hirokazu Shigematsu; Zhe Li; Benjamin H Lee; Jennifer Adelsperger; Rebecca Rowan; David P Curley; Jeffery L Kutok; Koichi Akashi; Ifor R Williams; Nancy A Speck; D Gary Gilliland
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

9.  Hematopoietic stem cell fate is established by the Notch-Runx pathway.

Authors:  Caroline Erter Burns; David Traver; Elizabeth Mayhall; Jennifer L Shepard; Leonard I Zon
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 11.361

10.  Grg1 acts as a lung-specific oncogene in a transgenic mouse model.

Authors:  Thaddeus Allen; Minke van Tuyl; Pratibha Iyengar; Serge Jothy; Martin Post; Ming-Sound Tsao; Corrinne G Lobe
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

View more
  44 in total

1.  Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.

Authors:  Nayan J Sarma; Nabeel R Yaseen
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Ras-Erk signaling induces phosphorylation of human TLE1 and downregulates its repressor function.

Authors:  T Zahavi; A Maimon; T Kushnir; R Lange; E Berger; D Kornspan; R Grossman; S Anzi; E Shaulian; R Karni; H Nechushtan; Z Paroush
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

3.  Impact of 9q deletions on the classification of patients with acute myeloid leukemia.

Authors:  Bettina Balk; Torsten Haferlach; Manja Meggendorfer; Wolfgang Kern; Claudia Haferlach; Anna Stengel
Journal:  J Cancer Res Clin Oncol       Date:  2019-03-29       Impact factor: 4.553

4.  TLE4 regulation of wnt-mediated inflammation underlies its role as a tumor suppressor in myeloid leukemia.

Authors:  Thomas H Shin; Christopher Brynczka; Farshid Dayyani; Miguel N Rivera; David A Sweetser
Journal:  Leuk Res       Date:  2016-07-21       Impact factor: 3.156

5.  A Case of AML-M2 with Sole Interstitial Deletion in 9q Without AML1-ETO/Inv 16 Rearrangement and FLT3/NPMI Mutations.

Authors:  G Sandhya Devi; Faiq Ahmed; Manasi C Mundada; S Sudha Murthy; Krishna Mohan Mallavarapu
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-23       Impact factor: 0.900

6.  Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.

Authors:  Pierre-Luc Mercier; Magdalena Bachvarova; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Karim Ghani; Bernard Têtu; Isabelle Bairati; Dimcho Bachvarov
Journal:  Mol Oncol       Date:  2011-07-26       Impact factor: 6.603

7.  Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.

Authors:  Weiqiang Li; Mridu Middha; Mesude Bicak; Daniel D Sjoberg; Emily Vertosick; Anders Dahlin; Christel Häggström; Göran Hallmans; Ann-Charlotte Rönn; Pär Stattin; Olle Melander; David Ulmert; Hans Lilja; Robert J Klein
Journal:  Eur Urol       Date:  2018-07-07       Impact factor: 20.096

8.  Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia.

Authors:  Sheeja T Pullarkat; Vinod Pullarkat; Steven H Kroft; Carla S Wilson; Arshad N Ahsanuddin; Karen P Mann; Maung Thein; Wayne W Grody; Russell K Brynes
Journal:  J Hematop       Date:  2009-02-10       Impact factor: 0.196

9.  Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhiheng He; Yunhua Liu; Deguang Liang; Zhuo Wang; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

Review 10.  Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia.

Authors:  Krzysztof Mrózek; Guido Marcucci; Peter Paschka; Clara D Bloomfield
Journal:  Curr Opin Oncol       Date:  2008-11       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.